|
Contents
|
|
|
|
Basic
Science |
|
|
|
|
Kubin A, Wierrani F, Burner U, Alth G, Grünberger W.
Hypericin--the
facts about a controversial agent.
Curr Pharm Des.
2005;11(2):233-53.
Abstract |
Reprint |
Related articles
|
|
|
Gliomas |
|
|
|
|
Couldwell
WT, Surnock AA, Tobia AJ, Cabana BE, Stillerman CB, Forsyth PA, Appley AJ,
Spence AM, Hinton DR, Chen TC.
A phase 1/2 study of orally administered synthetic hypericin for treatment
of recurrent malignant gliomas.
Cancer. 2011 Mar 31;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
|